Your session is about to expire
← Back to Search
Project MARS: Mobile-Assistance for Regulating Smoking
N/A
Waitlist Available
Led By Inbal Nahum-Shani, PhD
Research Sponsored by University of Utah
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up post-quit date - 6-month follow-up
Awards & highlights
No Placebo-Only Group
Summary
This trial will help researchers understand how to better help smokers quit by identifying when they are most vulnerable to lapse and most receptive to quitting aids.
Eligible Conditions
- Tobacco Smoking
- Smokers
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ post-quit date - 6-month follow-up
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~post-quit date - 6-month follow-up
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Biochemically Verified Smoking Abstinence
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
3Treatment groups
Experimental Treatment
Active Control
Group I: Effortful self-regulatory activitiesExperimental Treatment5 Interventions
Group II: Brief cognitive/behavioral strategiesExperimental Treatment4 Interventions
Group III: No activitiesActive Control1 Intervention
Find a Location
Who is running the clinical trial?
University of MichiganOTHER
1,863 Previous Clinical Trials
6,441,419 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,958 Previous Clinical Trials
41,112,468 Total Patients Enrolled
University of UtahLead Sponsor
1,147 Previous Clinical Trials
1,698,968 Total Patients Enrolled
Inbal Nahum-Shani, PhDPrincipal InvestigatorUniversity of Michigan
1 Previous Clinical Trials
400 Total Patients Enrolled
David Wetter, PhDPrincipal Investigator - University of Utah
University of Utah
1 Previous Clinical Trials
200 Total Patients Enrolled